Technology
Health
Medical
Ra Medical
$3.909876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$3.90
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.03 (0.78%) Today
+$0.03 (0.78%) Today
Why Robinhood?
You can buy or sell Ra Medical and other stocks, options, ETFs, and crypto commission-free!
About
Ra Medical Systems, Inc. engages in the design, development, and commercialization of excimer lasers for the treatment of dermatologic and cardiovascular diseases. Its product, Pharos, is used for the treatment of difficult-to-treat, chronic diseases including psoriasis and vitiligo. Read More It operates through the Dermatology and Vascular business segments. The company was founded by Dean Irwin and Melissa Burstein in 2002 and is headquartered in Carlsbad, CA.
CEO
Employees
118
Headquarters
Carlsbad, California
Founded
2002
Market Cap
49.11M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
112.44K
High Today
$4.00
Low Today
$3.81
Open Price
$3.99
Volume
39.11K
52 Week High
$22.00
52 Week Low
$3.76
Collections
Technology
Health
Medical
2018 IPO
US
North America
News
Seeking AlphaMar 15
Ra Medical down 28% on soft Q1 guidance
Thinly traded nano cap Ra Medical Systems (RMED -27.7% ) is down on modestly higher volume following its Q4 report released after the close yesterday.
Seeking AlphaMar 15
Ra Medical Systems, Inc. (RMED) CEO Dean Irwin on Q4 2018 Results - Earnings Call Transcript
Ra Medical Systems, Inc. (NYSE:RMED) Q4 2018 Earnings Conference Call March 14, 2019 4:30 PM ET Company Participants Kevin McCabe - LHA Investor Relations Dean Irwin - Chief Executive Officer, Chief Technology Officer and Chairman of the Board of Directors Thomas Fogarty - Chief Commercial Officer Andrew Jackson - Chief Financial Officer Conference Call Participants Andrew Stafford - Piper Jaffray Bruce Nudell - SunTrust Robinson Humphrey, Inc. Anthony Vendetti - Maxim Group, LLC Operator Ladies ...
BusinessWireMar 14
Ra Medical Systems Reports 2018 Fourth Quarter and Full Year Financial Results
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, today reported financial results for the three and 12 months ended December 31, 2018 and provided a business update. Recent Operational Highlights Signed 19 new DABRA usage agreements during the fourth quarter of 2018, increasing the total number of agreements to 53 as of December 31, 2018, with varying volumes o...
Price Paid on Robinhood
22% Lower
Right Now
52 Week Low
$3.76
Average Price Paid
$4.97
52 Week High
$22.00
Earnings
-$1.18
-$0.90
-$0.63
-$0.35
Q3 2018
Q4 2018
Estimated
-$0.38 per share
Actual
-$1.18 per share